MedTrace Logo

Secretome Treatment for Facial Rejuvenation

NCT07227883 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-05-04

No results posted yet for this study

Summary

Secretome treatment for facial rejuvenation

Conditions

  • Facial Aging
  • Rejuvenation
  • Stem Cell
  • Stem Cell Banking

Interventions

OTHER

Autologous Hair Follicle-Derived Secretome

This interventional product is a secretome derived from the stem cells that reside in the hair follicle.

OTHER

Control Saline

Saline solution will be the placebo control. The active is diluted with saline so this is an appropriate control.

Sponsors & Collaborators

  • Acorn Biolabs Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2026-12-20
Completion
2026-12-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07227883 on ClinicalTrials.gov